ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
703 hedge funds and large institutions have $22.6B invested in Alexion Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 261 increasing their positions, 262 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less call options, than puts
Call options by funds: $275M | Put options by funds: $315M
14% less funds holding in top 10
Funds holding in top 10: 21 → 18 (-3)
Holders
703
Holding in Top 10
18
Calls
$275M
Puts
$315M
Top Buyers
| 1 | +$324M | |
| 2 | +$150M | |
| 3 | +$94.5M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$91.5M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$67.7M |
Top Sellers
| 1 | -$495M | |
| 2 | -$367M | |
| 3 | -$107M | |
| 4 |
HM
HealthCor Management
New York
|
-$74.8M |
| 5 |
DnB Asset Management
Oslo,
Norway
|
-$74.1M |